|
1
|
Jennings RB, Sommers HM, Smyth GA, Flack
HA and Linn H: Myocardial necrosis induced by temporary occlusion
of a coronary artery in the dog. Arch Pathol. 70:68–78.
1960.PubMed/NCBI
|
|
2
|
Eltzschig HK and Eckle T: Ischemia and
reperfusion-from mechanism to translation. Nat Med. 17:1391–401.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sun G, Lu Y, Li Y, Mao J, Zhang J, Jin Y,
Li Y, Sun Y, Liu L and Li L: miR-19a protects cardiomyocytes from
hypoxia/reoxygenation-induced apoptosis via PTEN/PI3K/p-Akt
pathway. Biosci Rep. 37:BSR201708992017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang X, Ha T, Hu Y, Lu C, Liu L, Zhang X,
Kao R, Kalbfleisch J, Williams D and Li C: MicroRNA-214 protects
against hypoxia/reoxygenation induced cell damage and myocardial
ischemia/reperfusion injury via suppression of PTEN and Bim1
expression. Oncotarget. 7:86926–86936. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qiu R, Li W and Liu Y: MicroRNA-204
protects H9C2 cells against hypoxia/reoxygenation-induced injury
through regulating SIRT1-mediated autophagy. Biomed Pharmacother.
100:15–19. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kawaguchi M, Takahashi M, Hata T, Kashima
Y, Usui F, Morimoto H, Izawa A, Takahashi Y, Masumoto J, Koyama J,
et al: Inflammasome activation of cardiac fibroblasts is essential
for myocardial ischemia/reperfusion injury. Circulation.
123:594–604. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Feng R, Liu J, Wang Z, Zhang J, Cates C,
Rousselle T, Meng Q and Li J: The structure-activity relationship
of ginsenosides on hypoxia-reoxygenation induced apoptosis of
cardiomyocytes. Biochem Biophys Res Commun. 494:556–568. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Y, Shi X, Li J, Zhang M and Yu B:
Knockdown of KLF11 attenuates hypoxia/reoxygenation injury via
JAK2/STAT3 signaling in H9c2. Apoptosis. 22:510–518. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tutar Y: miRNA and cancer; computational
and experimental approaches. Curr Pharm Biotechnol. 15:4292014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lesizza P, Prosdocimo G, Martinelli V,
Sinagra G, Zacchigna S and Giacca M: Single-dose intracardiac
injection of Pro-regenerative MicroRNAs improves cardiac function
after myocardial infarction. Circ Res. 120:1298–1304. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li YG, Zhang PP, Jiao KL and Zou YZ:
Knockdown of microRNA-181 by lentivirus mediated siRNA expression
vector decreases the arrhythmogenic effect of skeletal myoblast
transplantation in rat with myocardial infarction. Microvasc Res.
78:393–404. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang J, Bai Y, Li N, Ye W, Zhang M, Greene
SB, Tao Y, Chen Y, Wehrens XH and Martin JF: Pitx2-microRNA pathway
that delimits sinoatrial node development and inhibits
predisposition to atrial fibrillation. Proc Natl Acad Sci USA.
111:9181–6. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rodriguez A, Vigorito E, Clare S, Warren
MV, Couttet P, Soond DR, van Dongen S, Grocock RJ, Das PP, Miska
EA, et al: Requirement of bic/microRNA-155 for normal immune
function. Science. 316:608–611. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Elton TS, Selemon H, Elton SM and
Parinandi NL: Regulation of the MIR155 host gene in physiological
and pathological processes. Gene. 532:1–12. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Faraoni I, Antonetti FR, Cardone J and
Bonmassar E: miR-155 gene: A typical multifunctional microRNA.
Biochim Biophys Acta. 1792:497–505. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nazari-Jahantigh M, Wei Y, Noels H, Akhtar
S, Zhou Z, Koenen RR, Heyll K, Gremse F, Kiessling F, Grommes J, et
al: MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in
macrophages. J Clin Invest. 122:4190–202. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Eisenhardt SU, Weiss JB, Smolka C,
Maxeiner J, Pankratz F, Bemtgen X, Kustermann M, Thiele JR, Schmidt
Y, Bjoern Stark G, et al: MicroRNA-155 aggravates
ischemia-reperfusion injury by modulation of inflammatory cell
recruitment and the respiratory oxidative burst. Basic Res Cardiol.
110:322015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nederlof R, Eerbeek O, Hollmann MW,
Southworth R and Zuurbier CJ: Targeting hexokinase II to
mitochondria to modulate energy metabolism and reduce
ischaemia-reperfusion injury in heart. Br J Pharmacol.
171:2067–2079. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tan L, Jiang W, Lu A, Cai H and Kong L:
miR-155 aggravates liver Ischemia/reperfusion injury by suppressing
SOCS1 in mice. Transplant Proc. 50:3831–3839. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Enright AJ, John B, Gaul U, Tuschl T,
Sander C and Marks DS: MicroRNA targets in drosophila. Genome Biol.
5:R12003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dweep H and Gretz N: miRWalk2.0: A
comprehensive atlas of microRNA-target interactions. Nat Methods.
12:6972015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kalia SK, Kalia LV and McLean PJ:
Molecular chaperones as rational drug targets for Parkinson's
disease therapeutics. CNS Neurol Disord Drug Targets. 9:741–753.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Harper SJ and LoGrasso P: Signalling for
survival and death in neurones: The role of stress-activated
kinases, JNK and p38. Cell Signal. 13:299–310. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lamb JA, Ventura JJ, Hess P, Flavell RA
and Davis RJ: JunD mediates survival signaling by the JNK signal
transduction pathway. Mol Cell. 11:1479–1489. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chan SH, Hsu KS, Huang CC, Wang LL, Ou CC
and Chan JY: NADPH oxidase-derived superoxide anion mediates
angiotensin II-induced pressor effect via activation of p38
mitogen-activated protein kinase in the rostral ventrolateral
medulla. Circ Res. 97:772–780. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shao Z, Bhattacharya K, Hsich E, Park L,
Walters B, Germann U, Wang YM, Kyriakis J, Mohanlal R, Kuida K, et
al: c-Jun N-terminal kinases mediate reactivation of Akt and
cardiomyocyte survival after hypoxic injury in vitro and in vivo.
Circ Res. 98:111–118. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kaelin WG Jr and Ratcliffe PJ: Oxygen
sensing by metazoans: The central role of the HIF hydroxylase
pathway. Mol Cell. 30:393–402. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Semenza GL: HIF-1 inhibitors for cancer
therapy: From gene expression to drug discovery. Curr Pharm Des.
15:3839–3843. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Epstein AC, Gleadle JM, McNeill LA,
Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI,
Dhanda A, et al: C. elegans EGL-9 and mammalian homologs define a
family of dioxygenases that regulate HIF by prolyl hydroxylation.
Cell. 107:43–54. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Brennan J: Reperfusion injury of cardiac
myocytes: Mechanisms, treatment, and implications for advanced
practice nursing. AACN Clin Issues. 11:252–260. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hausenloy DJ and Yellon DM: Myocardial
ischemia-reperfusion injury: A neglected therapeutic target. J Clin
Invest. 123:92–100. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Baines CP: How and when do myocytes die
during ischemia and reperfusion: The late phase. J Cardiovasc
Pharmacol Ther. 16:239–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Braunwald E: The war against heart
failure: The lancet lecture. Lancet. 385:812–824. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao ZQ: Oxidative stress-elicited
myocardial apoptosis during reperfusion. Curr Opin Pharmacol.
4:159–165. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Podsiad A, Standiford TJ, Ballinger MN,
Eakin R, Park P, Kunkel SL, Moore BB and Bhan U: MicroRNA-155
regulates host immune response to postviral bacterial pneumonia via
IL-23/IL-17 pathway. Am J Physiol Lung Cell Mol Physiol.
310:L465–L475. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bayraktar R and Van Roosbroeck K: miR-155
in cancer drug resistance and as target for miRNA-based
therapeutics. Cancer Metastasis Rev. 37:33–44. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gangwar RS, Rajagopalan S, Natarajan R and
Deiuliis JA: Noncoding RNAs in cardiovascular disease: Pathological
relevance and emerging role as biomarkers and therapeutics. Am J
Hypertens. 31:150–165. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhai A, Qian J, Kao W, Li A, Li Y, He J,
Zhang Q, Song W, Fu Y, Wu J, et al: Borna disease virus encoded
phosphoprotein inhibits host innate immunity by regulating miR-155.
Antiviral Res. 98:66–75. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cao S, Wang Y, Li J, Lv M, Niu H and Tian
Y: Tumor-suppressive function of long noncoding RNA MALAT1 in
glioma cells by suppressing miR-155 expression and activating FBXW7
function. Am J Cancer Res. 6:2561–2574. 2016.PubMed/NCBI
|
|
42
|
Teramura T and Onodera Y: Stem cell
depletion by inflammation-associated miR-155. Aging (Albany NY).
10:17–18. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tili E, Mezache L, Michaille JJ, Amann V,
Williams J, Vandiver P, Quinonez M, Fadda P, Mikhail A and Nuovo G:
microRNA 155 up regulation in the CNS is strongly correlated to
Down's syndrome dementia. Ann Diagn Pathol. 34:103–109. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bruchmann A, Roller C, Walther TV, Schafer
G, Lehmusvaara S, Visakorpi T, Klocker H, Cato AC and Maddalo D:
Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate
cancer and inhibits ER-stress induced apoptosis. BMC Cancer.
13:962013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Guo K, Li L, Yin G, Zi X and Liu L: Bag5
protects neuronal cells from amyloid β-induced cell death. J Mol
Neurosci. 55:815–820. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ying Z, Haiyan G and Haidong G: BAG5
regulates PTEN stability in MCF-7 cell line. BMB Rep. 46:490–494.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yue X, Zhao Y, Huang G, Li J, Zhu J, Feng
Z and Hu W: A novel mutant p53 binding partner BAG5 stabilizes
mutant p53 and promotes mutant p53 GOFs in tumorigenesis. Cell
Discov. 2:160392016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kalia SK, Lee S, Smith PD, Liu L, Crocker
SJ, Thorarinsdottir TE, Glover JR, Fon EA, Park DS and Lozano AM:
BAG5 inhibits parkin and enhances dopaminergic neuron degeneration.
Neuron. 44:931–945. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Bi L, Yang Q, Yuan J, Miao Q, Duan L, Li F
and Wang S: MicroRNA-127-3p acts as a tumor suppressor in
epithelial ovarian cancer by regulating the BAG5 gene. Oncol Rep.
36:2563–2570. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Bourke LT, McDonnell T, McCormick J,
Pericleous C, Ripoll VM, Giles I, Rahman A, Stephanou A and Ioannou
Y: Antiphospholipid antibodies enhance rat neonatal cardiomyocyte
apoptosis in an in vitro hypoxia/reoxygenation injury model via p38
MAPK. Cell Death Dis. 8:e25492017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Li Q, Xiang Y, Chen Y, Tang Y and Zhang Y:
Ginsenoside Rg1 protects cardiomyocytes against
hypoxia/reoxygenation injury via activation of Nrf2/HO-1 signaling
and inhibition of JNK. Cell Physiol Biochem. 44:21–37. 2017.
View Article : Google Scholar : PubMed/NCBI
|
